![Mark Donnison](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Mark Donnison worked as the Chief Executive Officer, Executive Director & MD at Medical Australia Ltd.
from 2014 to 2014.
He also worked as the Director-National Pharmacy Business at Alphapharm Pty Ltd.
Precedenti posizioni note di Mark Donnison
Società | Posizione | Fine |
---|---|---|
MEDICAL AUSTRALIA LIMITED | Amministratore Delegato | 12/02/2014 |
Alphapharm Pty Ltd.
![]() Alphapharm Pty Ltd. Pharmaceuticals: GenericHealth Technology Alphapharm has been developing and making generic medicines in Australia for more than 25 years. Millions of Australians take an Alphapharm generic medicine every day. In fact, It has become the largest supplier of medicines to the government subsidised Pharmaceutical Benefits Scheme and Australia's leader in generic medicines. Alphapharm medicines are available Australia-wide. Alphapharm medicines are made to the highest global quality standards and exported to more than 50 countries, including those in Europe and the US. Globally, Alphapharm is part of Mylan Inc., which provides products to customers in more than 140 countries and territories, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest - and highest quality - product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's third-largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Medical Australia Ltd.
![]() Medical Australia Ltd. Medical SpecialtiesHealth Technology Medical Australia Pty Ltd. engages in the development, manufacture, and distribution of medical devices and consumables used in the human and animal healthcare markets. It offers medication delivery, reuse prevention, and surgical devices. It operates through the following geographical segments: Australia, Asia, New Zealand, and United Kingdom. The company was founded on February 28, 2001 and is headquartered in Lidcombe, Australia. | Health Technology |
Alphapharm Pty Ltd.
![]() Alphapharm Pty Ltd. Pharmaceuticals: GenericHealth Technology Alphapharm has been developing and making generic medicines in Australia for more than 25 years. Millions of Australians take an Alphapharm generic medicine every day. In fact, It has become the largest supplier of medicines to the government subsidised Pharmaceutical Benefits Scheme and Australia's leader in generic medicines. Alphapharm medicines are available Australia-wide. Alphapharm medicines are made to the highest global quality standards and exported to more than 50 countries, including those in Europe and the US. Globally, Alphapharm is part of Mylan Inc., which provides products to customers in more than 140 countries and territories, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest - and highest quality - product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's third-largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies. | Health Technology |
- Borsa valori
- Insiders
- Mark Donnison